CBD Manufacturers Must Develop GMPs Even Absent FDA Instructions

Navigate Regulatory Uncertainty

Act now! Despite FDA guidance, uncertainty prevails. Responsible CBD manufacturers must prepare for future regulations.

Proactive GMP Preparation

Develop a robust "control framework" for seamless GMP compliance. This ensures readiness for future FDA regulations.

Aligning with Pharma Standards

CBD manufacturers face a learning curve in aligning with pharma-like GMP requirements. Understanding complexities is crucial for CBD market success.

Ensuring Safety and Efficacy

Validate critical processes to meet safety and efficacy standards. Verification and validation activities are pivotal for compliance.

From Farm to Pharma

Establish a dedicated quality unit and foster a quality-centric culture. Well-drafted SOPs and clear documentation ensure GMP compliance.

CBD Manufacturers Must Develop GMPs Even Absent FDA Instructions